Abiopharma

Ware J. Anthony 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

(90% Positive) PACIRA BIOSCIENCES, INC. (PCRX) Provides Update on leader for sustainable

Orwin John A 🟢 acquired 14.2K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

New Form 424B5 - Phathom Pharmaceuticals, Inc. Filed: 2026-01-08 AccNo: 0001193125-26-007653 Size: 799 KB

New Form S-3 - Avalo Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001104659-26-002118 Size: 1 MB

(85% Positive) Anika Therapeutics, Inc. (ANIK) Announces Regulatory Update

Viridian Therapeutics, Inc. - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Director Kauffman Michael 🟢 acquired 200.0K shares (1 derivative) of Verastem, Inc. (VSTM) at $6.88 ($1.4M) Transaction Date: Jan 06, 2026 | Filing ID: 002117

Inspira Technologies Oxy BHN (IINNW) Files Form 6-K

Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis

LILLY ENDOWMENT INC 🔴 sold 292.1K shares of ELI LILLY & Co (LLY) at $1,116.69 ($322.4M) Transaction Date: Jan 07, 2026 | Filing ID: 000003